慢性阻塞性肺疾病系统炎症相关因子研究进展

Abstract
Figure/Table
References
Related Citation (4)

[1] 李燕舞,刘春涛,曾雪峰.慢性阻塞性肺疾病与胰岛素抵抗的相关性研究[J].中国呼吸与危重监护杂志,2012,11(5):422-427.
[2] Ferrari R,Tanni S E,Caram L M,et al.Three-year follow-up of interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease[J].Respir RES,2013,14(24):691-694.
[3] Ju C,Chen R.Factors associated with impairment of quadriceps muscle function in Chinese patients with chronic obstructive pulmonary disease[J].PLoS One,2014,9(2):e84167.
[4] Zuo L,Hallman A H,Roberts W J,et al.Superoxide release from contracting skeletal muscle in pulmonary TNF-α overexpression mice[J]. Am J Physiol Regul Integr Comp Physiol,2014,306(1):R75-81.
[5] 范春红,李明霞,李明,等.COPD患者血清CRP、IL-1β、IL-17水平变化及临床意义[J].临床肺科杂志,2014,19(5):799-801.
[6] 杨凌婧.稳定期中重度慢阻肺患者血清 IL-6、IL-8、TNF-α、hs-CRP与肺功能的相关性研究[J].临床肺科杂志,2016,21(3):481-484.
[7] 杜伟.IL-8的变化在慢阻肺患者血清及支气管肺泡灌洗液中的应用价值研究[J].中外医学研究,2018,16(23):14-16.
[8] Shah S.Frequency of Metabolic Syndrome and Its Relationship With Systemic Inflammation in Patients of Chronic Obstructive Pulmonary Disease (COPD) in Ethnic Kashmiri Population of India[J].Chest,2014,145(3):400A.
[9] Deng Z C,Zhao P,Cao C,et al. C-reactive protein as a prognostic marker in chronic obstructive pulmonary disease[J].Exp Ther Med,2014,7(2):443-446.
[10] Tu Y H,Zhang Y,Fei G H.Utility of the CAT in the therapy assessment of COPD exacerbations in China[J].BMC Pulm Med,2014,14(1):42.
[11] Ahmadi-Abhari S,Kaptoge S,Luben R N,et al.Longitudinal association of C-reactive protein and lung function over 13 years: The EPIC-Norfolk study[J].Am J Epidemiol,2014,179(1):48-56.
[12] Lee S H,Kim C H,Yang K S,et al.Increased expression of vascular endothelial growth factor and hypoxia inducible factor-αin lung tissue of patients with chronic bronchitis[J].Clin Biochem,2014,21(13): 552-559.
[13] 吴刚.慢性阻塞性肺疾病患者血清基质金属蛋白酶、VEGF水平的变化及临床意义[J].临床肺科杂志,2018,23(1):79-82.
[14] 井军虎,李立宇,李建强.慢性阻塞性肺疾病患者血清淀粉样蛋白A水平变化及其与C-反应蛋白和白细胞介素-6的相关性[J].中国老年学杂志,2016,36(9):2185-2187.
[15] 凌杰兵 ,傅一牧,马斌.慢性阻塞性肺疾病急性加重期患者血清高迁移率蛋白 1、表面活性蛋白 D、肿瘤坏死因子-α 的表达及意义[J].中国临床医生杂志,2018,46(3):264-267.
[16] Liu Hu, Liu Jin-sheng,Huang Jin. Unique association of adiponectin isoforms with serum cytokines and redox molecules in patients with chronic obstructive pulmonary Disease[J].Chinese Medical Journal,2013,126(17):3383-3384.
[17] Nigro E,Scudiero O,Sarnataro D,et al.Adiponectin affects lung epithelial A549 cell viability counteracting TNF-α and IL-1β toxity through AdipoR1[J].Int J Biochem Cell Biol,2013,45(6):1145-1153.
[18] Bianco A,Mazzarella G,Turchiarelli V,et al.Adiponectin: an attractive marker for metabolic disorders in Chronic Obstructive Pulmonary Disease (COPD)[J].Nutrients,2013,5(10):4115-4125.